2025 was a big year for us and we’re excited to share some of the highlights that defined it!
Staying true to our mission of making reliable, high‑quality genetic tools accessible to everyone, in 2025 we shipped more than 5000 orders to our customers all over the world in 76 countries.
We value every opportunity to connect with our customer base and we were thrilled to meet you in person at 22 events across the globe to exchange experiences and ideas about our products and technologies. We also want to empower everyone who uses our products to get the most out of them by openly sharing our knowledge and insights. That's why, in 2025, we delivered 13 free online workshops – training more than 400 users of our products – to support you in analysing, inspecting, and troubleshooting your MLPA data.
Of course one of the standout moments of 2025 was the launch of two new digitalMLPA probemixes, NXtec™ D002 Hereditary Cancer Panel 2 & NXtec™ D024 KaryoProfiler, significantly expanding our portfolio of NGS-based assays for the detection of CNVs with the reliability and accuracy of MLPA.
Dedicated to keeping this momentum up, our product developers have been hard at work throughout the year developing many new and exciting digitalMLPA assays for a wide range of applications. We were able to share previews of our upcoming products and engage in dialogue with you about them by presenting no less than 11 posters at local and international scientific meetings.
Giving back is one of the cornerstones of MRC Holland's philosophy. For the 15th year, the majority of our profits went towards supporting the MRC Holland Foundation whose mission is to make education more accessible to children in developing countries with a focus on The Gambia.

Curious to know more about how the foundation has already impacted the lives of thousands of students in The Gambia?
Watch this video:
We are truly grateful for your continued support and trust in our company and we look forward to all the exciting developments that 2026 has in store!